{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:41Z","timestamp":1786118921672,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/dad.0b013e31817e23af","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T03:14:16Z","timestamp":1221534856000},"page":"466-471","source":"Crossref","is-referenced-by-count":14,"title":["Oral Lichenoid Lesions in HIV-HCV-Coinfected Subjects During Antiviral Therapy: 2 Cases and Review of the Literature"],"prefix":"10.1097","volume":"30","author":[{"given":"Michele","family":"Giuliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lajolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Sartorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Scivetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Capodiferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tumbarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/10454411980090010501","article-title":"Update on oral lichen planus: etiopathogenesis and management.","volume":"9","author":"Scully","year":"1998","journal-title":"Crit Rev Oral Biol Med"},{"key":"R3-11-20210202","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1034\/j.1600-0714.2003.00125.x","article-title":"Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications.","volume":"32","author":"Van der Meij","year":"2003","journal-title":"J Oral Pathol Med"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1601-0825.1997.tb00013.x","article-title":"Oral lichenoid drug eruptions.","volume":"3","author":"McCartan","year":"1997","journal-title":"Oral Dis"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-0825.1995.tb00178.x","article-title":"The histopathology of oral mucosal lesions associated with amalgam or porcelain-fused-to-metal restorations.","volume":"1","author":"Larsson","year":"1995","journal-title":"Oral Dis"},{"key":"R6-11-20210202","first-page":"48","article-title":"Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients.","volume":"55","author":"Pereira","year":"2007","journal-title":"Gen Dent"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(93)91029-H","article-title":"Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.","volume":"104","author":"Protzer","year":"1993","journal-title":"Gastroenterology"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4362.1994.tb04993.x","article-title":"Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon.","volume":"33","author":"Papini","year":"1994","journal-title":"Int J Dermatol"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1346-8138.1995.tb03424.x","article-title":"Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.","volume":"22","author":"Nunez","year":"1995","journal-title":"J Dermatol"},{"key":"R10-11-20210202","first-page":"825","article-title":"Lichen planus and chronic hepatitis C: exacerbation of the lichen under interferon-alpha-2a therapy.","volume":"8","author":"Areias","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2362.1996.610607.x","article-title":"Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C.","volume":"26","author":"Nagao","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(97)80296-4","article-title":"Oral erosive lichen planus with epidermolytic hyperkeratosis during alfa-2b therapy for chronic hepatitis C virus infection.","volume":"36","author":"Schlesinger","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0016-5085(99)70595-0","article-title":"Histological improvement of oral lichen planus in patients with chronic hepatitis C treated with interferon.","volume":"117","author":"Nagao","year":"1999","journal-title":"Gastroenterology"},{"key":"R14-11-20210202","first-page":"239","article-title":"Oral lichen planus induced by interferon--N1 in a patient with hepatitis C.","volume":"39","author":"Varela","year":"2000","journal-title":"Int J Dermatol"},{"key":"R15-11-20210202","first-page":"568","article-title":"Clinical evaluation in oral lichen planus with chronic hepatitis C: the role of interferon treatment.","volume":"97","author":"Sugiyama","year":"2000","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"R16-11-20210202","first-page":"358","article-title":"Presence of lichen planus during a course of interferon alpha-2a therapy for a viral chronic C hepatitis.","volume":"6","author":"Guijarro Guijarro","year":"2001","journal-title":"Med Oral"},{"key":"R17-11-20210202","first-page":"237","article-title":"Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.","volume":"15","author":"Nagao","year":"2005","journal-title":"Int J Mol Med"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1440-0960.2005.00131.x","article-title":"Complicated lichenoid drug eruption.","volume":"46","author":"Armour","year":"2005","journal-title":"Australas J Dermatol"},{"key":"R20-11-20210202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-005-0962-1","article-title":"Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions.","volume":"61","author":"Benahmed","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-138-3-200302040-00012","article-title":"Hepatitis C in the HIV-infected person.","volume":"138","author":"Sulkowski","year":"2003","journal-title":"Ann Intern Med"},{"key":"R22-11-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/154411130301400205","article-title":"Oral diseases possibly associated with hepatitis C virus.","volume":"14","author":"Carrozzo","year":"2003","journal-title":"Crit Rev Oral Biol Med"},{"key":"R23-11-20210202","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0714.2005.00372.x","article-title":"Immunohistopathological study of the oral lichenoid lesions of chronic GVHD.","volume":"35","author":"Sato","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"R24-11-20210202","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/154411130201300405","article-title":"The pathogenesis of oral lichen planus.","volume":"13","author":"Sugerman","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"R25-11-20210202","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.autrev.2004.11.005","article-title":"The immunological basis of lichenoid tissue reaction.","volume":"4","author":"Shiohara","year":"2005","journal-title":"Autoimmun Rev"},{"key":"R26-11-20210202","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.162.18.2125","article-title":"Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.","volume":"162","author":"De Luca","year":"2002","journal-title":"Arch Intern Med"},{"key":"R27-11-20210202","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"R28-11-20210202","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/01.aids.0000233571.51899.ab","article-title":"Interferon- differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.","volume":"20","author":"Rodriguez","year":"2006","journal-title":"AIDS"},{"key":"R29-11-20210202","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1128\/JVI.79.7.4109-4119.2005","article-title":"Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha\/beta interferon responsiveness and production.","volume":"79","author":"Jiang","year":"2005","journal-title":"J Virol"},{"issue":"suppl 1","key":"R30-11-20210202","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.qai.0000286598.00313.a6","article-title":"Antiretroviral treatment strategies and immune reconstitution in treatment-naive HIV-infected patients with advanced disease.","volume":"46","author":"Soria","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-11-20210202","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.det.2006.06.007","article-title":"Dermatologic manifestations of the immune reconstitution inflammatory syndrome.","volume":"24","author":"Lehloenya","year":"2006","journal-title":"Dermatol Clin"},{"key":"R32-11-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1601-0825.2001.70401.x","article-title":"Orofacial effects of antiretroviral therapies.","volume":"7","author":"Scully","year":"2001","journal-title":"Oral Dis"},{"key":"R33-11-20210202","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"R34-11-20210202","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00007890-200202150-00010","article-title":"Immunological and virological effects of ribavirin in hepatitis C after liver transplantation.","volume":"73","author":"Quadri","year":"2002","journal-title":"Transplantation"},{"key":"R35-11-20210202","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/AAC.48.9.3382-3389.2004","article-title":"Impact of alpha interferon and ribavirin on the function of maturing dendritic cells.","volume":"48","author":"Barnes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-11-20210202","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2893.2004.00496.x","article-title":"Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C.","volume":"11","author":"Marinho","year":"2004","journal-title":"J Viral Hepat"},{"key":"R37-11-20210202","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1053\/gast.2001.30126","article-title":"Unexpected low incidence of oral lichen planus in an HCV hyperendemic area of southern Italy.","volume":"121","author":"Mignogna","year":"2001","journal-title":"Gastroenterology"},{"key":"R38-11-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1386-6346(01)00114-0","article-title":"High incidence of extrahepatic manifestations in an HCV hyperendemic area.","volume":"22","author":"Nagao","year":"2002","journal-title":"Hepatol Res"},{"key":"R39-11-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2334\/josnusd.48.185","article-title":"Histochemical analysis of pathological alterations in oral lichen planus and lichenoid lesions.","volume":"48","author":"Juneja","year":"2006","journal-title":"J Oral Sci"},{"key":"R40-11-20210202","first-page":"234","article-title":"Direct immunofluorescence in oral lichen planus and oral lichenoid reactions.","volume":"33","author":"Raghu","year":"2002","journal-title":"Quintessence Int"},{"key":"R41-11-20210202","first-page":"175","article-title":"Evaluation of mast cells in oral lichen planus and oral lichenoid reaction.","volume":"12","author":"Jose","year":"2001","journal-title":"Indian J Dent Res"},{"key":"R42-11-20210202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2334\/josnusd.43.151","article-title":"Nuclear and cellular volumetric alterations immunofluorescence in oral lichen planus and lichenoid lesions: a histomorphometric study.","volume":"43","author":"Khoo","year":"2001","journal-title":"J Oral Sci"},{"key":"R43-11-20210202","first-page":"222","article-title":"Cutaneous adverse drug reactions to modern medicines and initial experiences from a spontaneous adverse drug reaction reporting program in a tertiary care teaching hospital of Western Nepal.","volume":"15","author":"Dubey","year":"2005","journal-title":"J Pak Assoc Dermatol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0b013e31817e23af","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:16Z","timestamp":1786036036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-200810000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31817e23af","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}